Business Wire

CARBIOS produces first PET-bottles from 100% recycled plastic waste using Company’s breakthrough technology

Del

Regulatory News:

CARBIOS (Paris:ALCRB) (Euronext Growth Paris: ALCRB), a company pioneering new, bioindustrial solutions to reinvent the lifecycle of plastic and textile polymers, today announced it has successfully produced the first PET-bottles made with 100% Purified Terephthalic Acid (rPTA), through the enzymatic biorecycling of plastic waste. This major milestone is a world-first and confirms the potential of the company’s technology to engage the whole industry in a responsible transition towards a circular economy.

Alain Marty, Chief Scientific Officer at CARBIOS, comments, “We have successfully developed the first biological process with which all kinds of PET plastic waste can be broken down into its original components and reused to produce virgin plastic products for applications such as PET-bottles. This new step shows the strong potential of CARBIOS’ enzymatic technology and provides a breakthrough solution to help solve society’s growing waste problem.

Previously, CARBIOS demonstrated that its proprietary biorecycling technology, based on the use of bioengineered enzymes, had the ability to turn PET plastic waste back into its original components at a rate of 97% in only 16 hours. It had also demonstrated that virgin PET can be made with 100% rPTA via its proprietary biorecycling process, which uses all kinds of post-consumer PET plastic bottles (clear, colored, opaque, complex). By demonstrating today that 100% rPTA can be used to produce

PET-bottles that match brand and customer requirements, this technology proves to be a potential game-changer in the transition towards a circular economy that will benefit the environment and future generations.

PET is the most common polyester on the market. It is used to produce plastic packaging, textile fibers, and nearly 500 billion units of plastic bottles each year1. It is a market expected to grow 4.8% annually, from 2017 to 20252. By decoupling the production of new plastic bottles from petrochemical feedstock3 and making waste collection economically more viable, CARBIOS’ technology offers a sustainable and efficient solution to change the way we produce some of the most commonly used plastic products and meet the needs of brand-owners and consumers.

1 Source: Citi GPS - Global Perspectives & Solutions – Rethinking Single-Use Plastics (August 2018)
2 Source: https://www.recycling-magazine.com/2019/01/24/market-study-sees-lots-of-potential-for-recycled-plastic/
3 See interesting reference: How much oil is used to make plastic? https://www.eia.gov/tools/faqs/faq.php?id=34&t=6

Jean-Claude Lumaret, CEO of CARBIOS, adds, “The plastics industry faces fundamental challenges related to sustainability. Our technology, based on a circular model, reuses resources rather than consuming them. This new milestone takes us one step closer to bringing our technology to the market. With the construction of our demonstration plant to start later this year, we’re aiming to engage the whole plastics industry in a transition towards a circular economy and take a leadership role as a global license provider for the biorecycling of PET plastics and fibers.”

Follow the link to discover more in video: Here

About CARBIOS:

CARBIOS is a green chemistry company whose innovations provide solutions to the environmental and sustainable development issues manufacturers currently face. Since its founding in 2011, the company has developed two industrial-scale biological processes for the biological breakdown and recycling of polymers. These unique innovations help optimise the performance and life cycle of plastics and textiles by capitalizing on the properties of specially selected enzymes. CARBIOS’s economic growth model is based on the industrial roll-out and sale of its products, enzymes, technologies and biological processes through direct licence agreements or joint ventures, to major players in the fields to whom they would most benefit. To that end, CARBIOS founded the joint venture CARBIOLICE in 2016, in partnership with Limagrain Céréales Ingrédients and the SPI fund, run by Bpifrance. This company, in which CARBIOS holds a controlling share, will market the first technology licensed by CARBIOS by producing enzyme pellets used in the production of biodegradable and bio-sourced plastics. Since its founding, CARBIOS has been backed by Truffle Capital, a European investment capital player. CARBIOS qualifies as an “Innovative Company” according to Bpifrance, which makes the company’s shares eligible for inclusion in innovation-focused mutual funds (FCPIs). For more information, please visit: www.carbios.fr

CARBIOS is also eligible for inclusion in SME share savings accounts (PEA-PMEs).

This press release does not constitute and cannot be regarded as constituting an offer to the public, an offer to sell or a subscription offer or as a solicitation to solicit a buy or sell order in any country.

Translation for information purposes only. In case of discrepancy between the French and the English version of this press release, the French version shall prevail.

Contact information

CARBIOS
Benjamin Audebert
Investor Relations
contact@carbios.fr
+33 (0)4 73 86 51 76

Media Relations (Europe)
Alize RP
Caroline Carmagnol
carbios@alizerp.com
+33 (0)1 44 54 36 66

Media Relations (U.S.)
Rooney Partners
Kate L. Barrette
kbarrette@rooneyco.com
+1 212 223 0561

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Concierge Auctions and Engel & Völkers to Sell $29.9 Million New Jersey Estate Without Reserve20.5.2019 17:32:00 CESTPressemelding

A 32,507-square-foot Saddle River residence will sell at auction next month via leading global firm Concierge Auctions. Known as “Stone Palace on the Hill,” the home features a glass elevator, tennis court, racquetball court, wine cellar, and two swimming pools. 144 East Saddle River Road was previously listed for $29.9 million and will sell Without Reserve in cooperation with Alina Pogorelova and Lisa Troyano-Ascolese of Engel & Völkers. Bidding, which will be held via Concierge Auctions’ online marketplace, will open on June 21st and close on June 27. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005686/en/ 144 East Saddle River Road | New York Metro, NJ (Photo: Business Wire) “The quality of work and detail that went into building this home is perhaps the most impressive element of the property,” said Troyano-Ascolese. “With astounding details from custom gold-plated and forged-iron railings to a complete hand-cut

CNIM to Optimize Renewable Heat Production for Nantes District Heating20.5.2019 17:20:00 CESTPressemelding

CNIM, a French international industrial equipment manufacturer and integrator, has entered into an agreement concerning the energy efficiency optimisation at the waste-to-energy plant serving the cities of Nantes and Saint Nazaire, in the North West of France. Under the terms of this agreement, CNIM will install an absorption heat pump to boost the supply of hot water to Nantes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005678/en/ Heat-Pump_13MW_Brive (c) CNIM The delivery is scheduled for October 2019. The new system has been designed to inject 3.1 MW of heat energy into Nantes' district heating system. 2018: Two contracts to upgrade heat networks in France and Switzerland Prior to this agreement, CNIM won two other major contracts to upgrade the energy efficiency of waste-to-energy plants in France and Switzerland, and to supply district heating networks with renewable energy. Supplying 30 MW to Basel's district

MyHeritage utvides til Helse; Lanserer ny DNA-test som tilbyr omfattende og personlig helseinnsikt for forbrukere20.5.2019 17:15:00 CESTPressemelding

MyHeritage, den ledende globale tjenesten for familiehistorie og DNA-testing, kunngjorde i dag en stor utvidelse av DNA-produktlinjen med lanseringen av MyHeritage DNA Helse+Aner-testen. Testen gir en ny dimensjon av genetisk innsikt med omfattende helserapporter som kan styrke fremtidige helse- og livsstilsvalg. Det er en utvidelse av den nåværende MyHeritage DNA-testen, og inkluderer sine søylefunksjoner: en prosentvis nedbryting av etnisk opprinnelse og samsvar med slektninger gjennom delt DNA. MyHeritage er nå det eneste globale DNA-selskapet for forbrukere som tilbyr et omfattende helse- og aneprodukt på over 40 språk. Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20190520005670/no/ MyHeritage utvides til Helse; Lanserer ny DNA-test som tilbyr omfattende og personlig helseinnsikt for forbrukere (Graphic: Business Wire) Lanseringen av Helse+Aner-produktet skiller MyHeritage som den eneste hovedtjenesten som forbinde

Phase III study showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis associated ILD120.5.2019 16:46:00 CESTPressemelding

Boehringer Ingelheim today announced that the SENSCIS® trial met its primary endpoint: reduction in the annual rate of decline in forced vital capacity (FVCa) in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD). Results show that nintedanib slows the loss of pulmonary function in patients with SSc-ILD compared to placebo. Patients taking nintedanib showed a 44% reduction in the rate of decline of their lung function, measured in FVC assessed over 52 weeks1. These new data were today published in the New England Journal of Medicine (NEJM) and presented to the medical community at the American Thoracic Society (ATS) International Conference, in Dallas, USA. SENSCIS® is the largest randomised controlled trial to be conducted in patients with SSc-ILD, a disease for which there are currently no approved treatments.1,3,4 Results also showed that nintedanib had a safety and tolerability profile similar to that observed in patients with idiopathic pulmonary fibro

Airship Bolsters its Senior Leadership Team for Accelerated Global Growth20.5.2019 13:00:00 CESTPressemelding

Customer engagement company Airship today announced four senior leadership appointments including Dale Flores as vice president of sales Americas, Neil Gariepy as vice president of infrastructure and security, David King Harris as vice president of sales EMEA, and Jeff Winsor as vice president of technology services. Dale Flores will lead the rapid expansion of Airship’s Americas sales organization, growing solution adoption to generate greater business value for customers throughout the region. Flores brings two decades of global SaaS sales and customer success management experience to Airship, including over 14 years leading sales teams at Silverpop and IBM. Most recently, Flores was head of customer success at digital customer experience company Clicktale. Neil Gariepy will lead Airship’s customer engineering, infrastructure and security teams, with responsibility for expanding Airship’s infrastructure globally while further optimizing its cost, performance and security. Gariepy bri

Analogix Introduces Its VirtualLink™ Reference Design for High-Performance Gaming Notebooks20.5.2019 13:00:00 CESTPressemelding

Analogix Semiconductor, Inc. today announced the availability of its VirtualLink™ Reference Design which enables VirtualLink directly on the motherboard of high-performance gaming notebooks, allowing them to support virtual reality (VR) over the USB-C™ connector. External accessories can also leverage the reference design to interface legacy graphics processing units (GPUs) to future VirtualLink-enabled VR head-mounted displays. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005132/en/ Analogix VirtualLink™ Reference Design brings VR support over the USB-C™ connector to high-performance gaming laptops. (Graphic: Business Wire) Introduced by a consortium led by NVIDIA, Oculus, Valve, AMD, and Microsoft, the VirtualLink Alternate Mode of USB Type-C™ was designed to deliver the power, display, and data required to power VR headsets through a single USB Type-C connector, eliminating the need for multiple cables. It expands